Sensorion Completes Second Cohort Enrollment in OTOF Gene Therapy Clinical Trial
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
Category: Hearing Disorders
Hearing Disorders
Latest
Hearing Disorders
Latest
60 Percent of Childhood Hearing Loss Preventable
A new review highlights the underrecognized potential of vaccines to prevent childhood hearing loss, especially in low- and middle-income countries.
Hearing Disorders
Latest
Cilcare Secures Funding to Advance Clinical Trials for Cochlear Synaptopathy Treatment
Cilcare raised €40 million in Series A funding to initiate two clinical trials in 2025 for treatment of cochlear synaptopathy.
Auditory Processing Disorders
Latest
Are COVID-19 “Brain Fog” Symptoms and an Auditory Processing Disorder Related?
When a COVID-19 survivor reports that they have been diagnosed with brain fog or mild cognitive impairment (BF/MCI), or these terms appear in a medical report, hearing care professionals should be aware that many of the BF/MCI symptoms are very similar to those seen in patients with (central) auditory processing disorder. This article by audiologist Robert DiSogra, AuD, reviews the research on this subject and provides recommendations.
Conductive
Latest
‘Discover Magazine’ Article Challenges Notion of Deafness as Something to Be ‘Cured’
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
Sensorineural
Latest
Mass Eye and Ear Researchers Awarded $12.5 Million Grant
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders (NIDCD) of the National Institutes of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage first discovered at Mass Eye and Ear in 2009.
Meniere’s, Mixed, Syndromic
Latest
Spiral Therapeutics Partners with the Vestibular Disorders Association on Patient-Centric Care in Neurotology
Spiral Therapeutics is partnering with the Vestibular Disorders Association to improve the lives of patients suffering from balance disorders.